OptiMedica’s Catalys™ Precision Laser System Study Published in Science Translational Medicine Shows Marked Advancement in Cataract Surgery

SANTA CLARA, Calif.--(BUSINESS WIRE)--Global ophthalmic device company OptiMedica Corp. has announced that results from a clinical study of its Catalys Precision Laser System were published in the peer-reviewed journal Science Translational Medicine (“Femtosecond Laser-Assisted Cataract Surgery with Integrated Optical Coherence Tomography,” Volume 2, Issue 58, November 17, 2010). The data showed that, when compared to manual techniques, the Catalys Precision Laser System helped surgeons achieve significant improvement in precision during several critical steps of cataract surgery.

“These study results clearly indicate that a femtosecond laser with integrated Ocular Coherence Tomography (OCT) imaging, advanced optics and control software can provide multiple benefits for cataract surgery,” said the study’s lead author Daniel Palanker, associate professor, Department of Ophthalmology and Hansen Experimental Physics Laboratory, Stanford University. “We believe the new laser-assisted technique represents a significant scientific and clinical advancement that will make cataract surgery much more precise and reproducible, and we are gratified that Science Translational Medicine has recognized its importance and potential.”

As reported in the published study, approximately one third of Americans will undergo cataract surgery in their lifetime. While advancements in surgical technique have occurred over the last several decades, several critical steps remain manual in nature and can only be performed with limited precision.

source: Business Wire